Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for systemic inflammatory response syndrome in ICU patients
ACTRN12614001165673Phase 2Terminated
- Sponsor
- Austin Health
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Systemic Inflammatory Response Syndrome (SIRS) comparing Aspirin with Placebo (2 arms). Primary endpoint: Serum interleukin-6 concentration. Started Mar 2015; status: terminated.
02
Drugs
aspirin
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on ACTRN12614001165673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001165673.